UpToDate
Depends
Confidence: Medium
Buy if you're a practicing clinician without institutional access and can absorb ~$580/yr.
New check
Comparison
UpToDate and Iatrox both land on Depends.
Buy if you're a practicing clinician without institutional access and can absorb ~$580/yr.
UK doctors, GP trainees and medical students get a free, NICE-grounded reference and Q-bank that is low-risk to try.
| Compare | ||
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Practicing physicians, NPs, PAs | UK doctors and GP trainees |
| Who it's not for | Non-clinicians. This is physician-grade reference, not consumer health advice | Clinical decisions needing validated, regulated decision support |
| Privacy | No known public vulnerabilities found in the sources reviewed.⁵ | No known public vulnerabilities found in the sources reviewed. |
| Support quality | No support evidence in sources | No evidence in reviewed sources |
| Public sentiment | Clinicians overwhelmingly treat UpToDate as their go-to point-of-care reference, with the ~$580 price the main complaint.¹ | Doctors share it organically in Facebook and Reddit groups for its free access, but independent review-site ratings are absent.15 |
| Biggest gotcha | Institutional access can vanish. Some universities dropped subscriptions, forcing personal payment³ | AI outputs can be wrong. Vendor's own protocol says test before professional reliance |